Building a bridge to Japan with biotech business intelligence

transB’s vision is to provide clients with the best insights and analyses of cutting edge science, products and business opportunities and help implement successful cross-border transactions. The role of transB is to act as a powerful catalyst that bridges the gap between Japanese biotech communities and the global stage. 

Current projects

transB advises on strategy and implementation of various cross-border transactions, such as licensing, investment and joint venture formation. Here are some examples of current projects which have been anonymised.

1. US joint venture formation around a Japanese therapeutic asset in ophthalmology

2. Seeking foreign co-investment candidates for a new Japanese biotech fund

3. Overseas research alliance formation for a Japanese stem cell company

4. Roadshow for a European pharma for launching European marketed product in Japan

5. Seeking Japanese corporate investor for a technology owned by a European biotech company 

6. Seeking drug development partners in Asia for a therapeutic protein approved in Europe

7. Seeking drug discovery partners in Japan for a European platform technology company

8. Promoting inward investment opportunities to European medical device companies

We are very flexible in the way that we work and are keen to discuss your business needs. For more information, contact Chizuko Koseki at c.koseki@transb.co.uk.